Nootropics in Complex Therapy of Chronic Cerebral Ischemia

Authors

  • I.S. Chekman O.O. Bogomolets National Medical University, Kyiv
  • I.F. Belenichev Zaporizhia State Medical University, Zaporizhia
  • A.V. Demchenko Zaporizhia State Medical University, Zaporizhia
  • V.I. Bobrova P.L. Shupyk National Medical Academy of Postgraduate Education, Kyiv
  • L.I. Kucherenko O.O. Bogomolets National Medical University, Kyiv
  • N.A. Gorchakova Zaporizhia State Medical University, Zaporizhia
  • N.V. Bukhtiyarova Zaporizhia State Medical University, Zaporizhia

DOI:

https://doi.org/10.15407/scine10.04.056

Keywords:

cerebrovascular diseases, cognitive disorders, neuroprotection, nootropics

Abstract

The clinical and pharmacological characteristics of nootropics as one of the most effective groups of neuropsychotropic drugs have been considered. The nootropics has been classified by the principal mechanism of action. The examples of clinical use of drugs on patients with chronic cerebral ischemia have been given.

References

Luschyk, U.B. and Alekseeva, T.S.: Why Do Mortality and Disease Incidence Related to Cardiovascular Pathology Not Decline? Practical Angiology, 3 (32), 5—11 (2010) (in Ukrainian).

Mischenko, T.S.: Epidemiology of Neurological Diseases in Ukraine. NeuroNEWS, 3, 76—77 (2008) (in Ukrainian).

Hacke W., Kaste, M., Skyhoi Olsen, T. et al.: Acute Treatment of Ischemic Stroke.Cerebrovascular Diseases, 10, 1—11 (2000).

https://doi.org/10.1159/000047578

Netiazhenko, V. and Malchevska, T.: Anti-Thrombocyte Strategy of Primary and Secondary Prevention of Cardiovascular Accidents (Based on Materials of Consensus on Use of Anti-Thrombocyte Drugs). Medicines of Ukraine, 6, 13—20 (2004) (in Ukrainian).

Zozulia I.S. and Zozulia, A.I.: Epidemiology of Cerebrovascular Diseases in Ukraine. Ukrainian Medical Journal, 5 (85), 38—41 (2011) (in Ukrainian).

Moroz, V.A.: Discirculatory Encephalopathy: Modern Approach to Treatment and Prevention. Pharmacist. 9, 20—23 (2008) (in Ukrainian).

Mischenko, T.S., Zdesenko, I.V., Linskaya, A.V., and Mischenko, V.N.: New Targets of Therapy in Patients with Chronic Cerebral Ischemia. International Neurological Journal, (40), 7—17 (2011) (in Russian).

Schmidt, E.V.: Classification of Vascular Affections of Brain and Spinal Cord. Journal of Neurology and Psychiatry, 9, 1281—1288 (1985) (in Russian).

Damulin, I.V., Parfenov, V.A., Skoromets, A.A., and Uakhno, N.N. (2003). Blood Circulation Failure in Brain

and Spinal Cord. In Yakhno, N.N. (ed.), Neural System Disorders: Manual for Therapists. Moscow: Medicine, 231—302 (in Russian).

Levin, O.S.: Modern Approaches to Diagnostics and Treatment of Discirculatory Encephalopathy. International Neurological Journal, 1(47), 117—124 (2012) (in Russian).

Pantoni L., Poggesi A., and Inzitari D.: The Relation between White Matter Lesions and Cognition. Curr. Opin. Neurol. 20, 390—397 (2007).

https://doi.org/10.1097/WCO.0b013e328172d661

Roman, G.C., Erkinjuntti, T., Wallin, A. et al.: Subcortical Ischemic Vascular Dementia. Lancet Neurology, 1, 426—436 (2002).

https://doi.org/10.1016/S1474-4422(02)00190-4

Zakharov, V.V. and Yakhno, N.N.: Treatment of Mild and Moderate Cognitive Disorders. Russian Medical Journal, 10, 797—801 (2007) (in Russian).

Yakhno, N.N.: Cognitive Disorders in Neurological Clinical Picture. Neurological Journal, II (Annex 1), 4—13 (2006) (in Russian).

Bowler, J.V.: Vascular Cognitive Impairment. J. Neurol. Neurosurg. Psychiatry, 76 (Suppl. V), 35—44 (2005).

https://doi.org/10.1136/jnnp.2005.082313

De Haan, E.H., Nys, G.M., and Van Zandvoort, M.J.V.: Cognitive Function Following Stroke and Vascular Cognitive Impairment. Curr. Opin. Neurol, 19, 559—564 (2006).

https://doi.org/10.1097/01.wco.0000247612.21235.d9

Yavorskaya, V.A., Flomin Yu.V., and Grebeniuk, A.V.: Approaches to the Study of Cognitive Functions at Cerebrovascular Diseases and Other Cerebral Organic Affections: Survey of Foreign Publications. International Neurological Journal, 2 (18), 131—137 (2008) (in Russian).

Lovenstone, S. and Gauthier, S. (2001). Management of Dementia. London: Martin Dunitz.

Hodges, J.R.: Cognitive Assessment for Clinicians. J. Neurol. Neurosurg. Psychiatry, 76, 22—30 (2005).

https://doi.org/10.1136/jnnp.2004.059758

Belenichev, I.F., Chernyi, V.I., and Kolesnik, Yu.M. (2009). Rational Neuroprotection. Donetsk: Zaslavskii Publishing House (in Russian).

Gusev, E.I. and Skvortsova, V.I. (2001). Cerebral Ischemia. Moscow: Medicine (in Russian).

Vereschagin, N.V., Morgunov V.A., and Gulevskaia, T.S. (1997). Cerebral Pathology at Arthrosclerosis and Arterial Hypertension. Moscow: Medicine (in Russian).

Yakhno, N.N., Levin, O.S., and Damulin, I.V.: Comparison of the Clinical and the MRT Data in the Treatment of Discirculatory Encephalopathy. Report 2: Cognitive Disorders. Neurological Journal, 6, 3, 10—19 (2001) (in Russian).

Belenichev, I.F., Mazur, I.A., and Stets, V.R.: Nootropic Therapy: the Past, the Present, and the Future. News of Medical Science and Pharmacology, 15 (155), 10 (2004) (in Russian).

Burchinskii, S.G.: Prospects for Nootropic Drugs for Treatment of Discirculatory Encephalopathy. Journal of Practitioner, 2, 51—55 (2005) (in Russian).

Suslina, Z.A., Maksimova, M.Yu., and Fedorova, T.N.: Chronic Cerebrovascular Diseases: Clinical and Antioxidative Efficacy of Mildronate. The Therapist, 4, 44—48 (2007) (in Russian).

Chernii, V.I., Kolesnikov, A.N., and Gorodnik, G.A. (2007). Cerebral Ischemia in Medical Science of Critical Conditions. Neuroprotection (Pathophysiology, Terminology, and Properties of Drugs): Methodical Recommendations (Manuscript copyright). Kyiv (in Russian).

Gusev, E.I., Skvortsova, V.I., and Platonova, I.A.: Ischemic Stroke Therapy. Consilium Medicum, 5, 8, 21— 29 (2003) (in Russian).

Suslina, Z.A., Fedorova, T.N., and Maksimova, M.Yu.: Antioxidant Therapy for the Treatment of Ischemic Stroke. Journal of Neurology and Psychiatry, 100, 10, 34—38 (2000) (in Russian).

Ciani, E.: Inhibition of Free Radical Production or Free Radical Scavenging Protects from the Excitotoxic Cell Death Mediated by Glutamate in Cultures of Cerebellar Granule Neurons. Brain Res. 728, 11, 1—6 (1996).

https://doi.org/10.1016/0006-8993(96)00382-4

Chekman, I.S., Gorchakova, N.A., Kazak, L.I, et al. (2013). Pharmacology: Manual for HEE Students. Vinnytsia: Nova Knyha (in Russian).

Chernii, V.I., Kalmykova, T.N., and Chernii, E.V. (2008). Intensive Therapy of Critical Condition Caused by Cerebral Stroke: Methodical Recommendations (Manuscript copyright). Kyiv (in Russian).

Aleksandrov, Yu.I., Grechenko, T.N., and Gavrilov, V.V.: Regularities of Formation and Implementation of Individual Experience. Journal of Higher Nervous Activity, 1, 2, 34—45 (1997) (in Russian).

Adibhafla, R.M. and Hatcher, J.F.: Citidine 5-Diphosphocholine (CDP-Choline) Insfroke and Ofher CNS Disorders. Neurochemical Research, 30, 15—23 (2005).

https://doi.org/10.1007/s11064-004-9681-8

Adibhatla, R.M. and Hatcher, J.F.: Citicoline Mechanismus and Clinical Efficacy in Cerebral Ischemia. J. of Neuroscience Research, 70, 133—139 (2002).

https://doi.org/10.1002/jnr.10403

Levin, O.S.: Use of Citicoline for the Treatment of Stroke. Russian Medical Journal, 26, 1772—1777 (2008) (in Russian).

Skvortsova, V.I. and Boitsova, A.: Neuroprotective Citicoline Therapy in the Acute Period of Ischemic Stroke. The Therapist, 12, 25—28 (2007) (in Russian).

Adibhatla, R.M., Hatcher, J.F., and Dempsey, R.I.: Citicoline: Neuroprotective Mechanisms in Cerebral Ischemia. J.Nerocuem., 80, 12—13 (2002).

Cobo, E., Secades, J.J., Miras, F. et al.: Boosting the Chances to Improve Stroke Treatment. Stroke, 41, 143—150 (2010).

https://doi.org/10.1161/STROKEAHA.109.567404

Saver, J.L.: Citicoline: Update on a Promising and Widely Available Agent for Neuroprotection and Neurorepair. Rev. Neurol. Dis., 5, 167—177 (2008).

Fioravanti, M., Buckley, A.E., and Agnoli, A. (1982). Citicoline in CCVD Patients: Preliminary Results of a Multicenter Study. Cerebral Pathology in Old Age: Neuroradiological and Neurophysiological Correlations. Pavia.

Agnoli, A., Fioravanti, M., Lechner, H., and Zappia V. (1985). Efficacy of CDPcholine in Chronic Cerebral Vascular Diseases (CCV). In: Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. Amsterdam: Elsevier, 305—315.

Chandra, B.: Treatment of Multi-Infarct Dementia with Citicoline. J Stroke Cerebrovasc Dis., 2, 232—233 (1992).

https://doi.org/10.1016/S1052-3057(10)80055-2

Capurso, A., Capurso, S., Panza, F. et al.: Efficacy of Cytidine Diphosphate Choline in Patients Affected by Chronic Cerebrovascular Disease. Clin Drug Invest., 12, 26—38 (1996).

https://doi.org/10.2165/00044011-199612010-00004

Tanaka, Y., Minematsu, K., Hirano, T. et al.: Effects of CDPcholine on Dynamic Changes in LCBF and Cognitive Function in Demented Subjects-PET Study. Rinsho Shinkeigaku, 34, 877—881 (1994).

Cacabelos, R., Alvarez, X.A., Franco, A. et al.: Therapeutic Effects of CDPcholine in Alzheimer’s Disease and Multiinfarct Dementia. Ann Psychiat., 3, 233—245 (1992).

Amenta, F., Di Tullio, M.A., and Tomassoni, D.: The Cholinergic Approach for the Treatment of Vascular Dementia: Evidence from Pre-Clinical and Clinical Studies. Clin Exp Hypertens., 24, (2002).

Fioravanti, M. and Yanagi, M.: Cytidinediphosphocholine (CDPcho line) for Cognitive and Behavioural Disturbances Associated with Chronic Cerebral Disorders in the Elderly. The Cochrane Database of Systematic Reviews, 3 (2009).

Blvarez-Sabhn, J., Ortega, G., Jacas, C. et al.: Citicoline Treatment Prevents Neurocognitive Decline after a First Ischemic Stroke. Cerebrovasc. Dis., 29 (Suppl. 2), 268 (2010).

Secades, J. and Lorenzo, J.: Citicoline. Pharmacol Clin Rev., 27 (Suppl. B), 1—56 (2006).

Renshaw, P.F., Babb, S.M., Yurgelun-Todd, D.A. et al.: Chronic Citicholine (CDP-choline administration Alters Brain Phospholipid Metabolites and Improves Cognitive Performance in Healthy, Older Adults. 37th ACNP Annual Meeting: Puerto Rico, (1998).

Fioravanti, M. and Yanagi, M.: Cytidinediphosphocholine (CDP-choline) for Cognitive and Behavioural Disturbances Associated with Chronic Cerebral Disorders in the Elderly. Cochrane Database Syst. Rev., 18, CD000269 (2005).

Fioravanti, M. and Buckley, A.E.: Citicoline (Cognizin) in the Treatment of Cognitive Impairment. Clin. Interv. Aging, 1, 247—251 (2006).

https://doi.org/10.2147/ciia.2006.1.3.247

Mazza, M., Capuano, A., Bria, P., and Mazza S.: Ginkgo Biloba and Doneperesil: a Comparison in the Treatment of Alzheimer’s Dementia in a Randomized Placebo-Controlled Double-Blind Study. Eur. J. Neurol., 13, 9, 981—85 (2006).

https://doi.org/10.1111/j.1468-1331.2006.01409.x

Mazur, I.A., Belenichev, I.F., and Kucherenko, L.I.: Patent of Russian Federation no. 2248203, appl. No. 2003104538/15 of 14.02.2003 (in Russian).

Dziak, L.A. and Golik, V.A.: Efficacy of Thiocetam for the Treatment of Discirculatory Encephalopathy Caused by Atherosclerotic Disease of Cerebral Arteries. News of Medical Science and Pharmacology, 10-11, 4—5 (2004) (in Russian).

Kuznetsova, S.M., Kuznetsov, V.V., and Vorobei, V.M.: Thiocetam Effect on Functional Condition of Patients Who Have Suffered Stroke. International Neurological Journal, 1, 45—51 (2005) (in Russian).

Dziak, L.A., Miziakina, E.V., and Pavlov, A.I.: Post Traumatic Mnestic Disorders. International Neurological Journal, 8 (46), 11—19 (2011) (in Russian).

Downloads

Published

2024-08-13

How to Cite

Chekman, I., Belenichev, I., Demchenko, A., Bobrova, V., Kucherenko, L., Gorchakova, N., & Bukhtiyarova, N. (2024). Nootropics in Complex Therapy of Chronic Cerebral Ischemia. Science and Innovation, 10(4), 56–68. https://doi.org/10.15407/scine10.04.056

Issue

Vol. 10 No. 4 (2014): Science and Innovation

Section

The World of Innovation

License

Copyright (c) 2024 Copyright Notice Authors published in the journal “Science and Innovation” agree to the following conditions: Authors retain copyright and grant the journal the right of first publication. Authors may enter into separate, additional contractual agreements for non-exclusive distribution of the version of their work (article) published in the journal “Science and Innovation” (for example, place it in an institutional repository or publish in their book), while confirming its initial publication in the journal “Science and innovation.” Authors are allowed to place their work on the Internet (for example, in institutional repositories or on their website).

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.